Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses.

Joseph, Jeswin; Karthika, T; Das, V R Akshay; Raj, V Stalin

Joseph, Jeswin; Karthika, T; Das, V R Akshay; Raj, V Stalin.

Joseph J; Virology Scientific Research (VSR) Laboratory, School of Biology, Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM), India.
Karthika T; Virology Scientific Research (VSR) Laboratory, School of Biology, Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM), India.
Das VRA; Virology Scientific Research (VSR) Laboratory, School of Biology, Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM), India.
Raj VS; Virology Scientific Research (VSR) Laboratory, School of Biology, Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM), India. Electronic address: stalin@iisertvm.ac.in.

J Glob Antimicrob Resist ; 26: 26-28, 2021 09.

Article in English | MEDLINE | ID: covidwho-1244765

Subject(s)

COVID-19; Catechin; Middle East Respiratory Syndrome Coronavirus; Catechin/analogs & derivatives; Catechin/pharmacology; Humans; Middle East Respiratory Syndrome Coronavirus/genetics; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Catechin / Middle East Respiratory Syndrome Coronavirus / COVID-19 Limits: Humans Language: English Journal: J Glob Antimicrob Resist Year: 2021 Document Type: Article Affiliation country: J.jgar.2021.05.005

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google